Capstone Investment Advisors
RMD icon

Capstone Investment Advisors’s ResMed RMD Stock Holding History

Capstone Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,300
Closed -$356K – 1976
2025
Q3 		$356K Sell
1,300
-100
-7% -$27.3K ﹤0.01% 1565
2025
Q2 		$361K Sell
1,400
-900
-39% -$215K ﹤0.01% 1298
2025
Q1 		$515K Buy
2,300
+300
+15% +$70K ﹤0.01% 1069
2024
Q4 		$457K Sell
2,000
-800
-29% -$193K ﹤0.01% 1341
2024
Q3 		$684K Buy
2,800
+400
+17% +$89.4K ﹤0.01% 1104
2024
Q2 		$459K Sell
2,400
-100
-4% -$20.3K ﹤0.01% 1357
2024
Q1 		$495K Buy
2,500
+600
+32% +$110K ﹤0.01% 1561
2023
Q4 		$327K Buy
1,900
+1,500
+375% +$230K ﹤0.01% 1557
2023
Q3 		$59.1K Hold
400
– – ﹤0.01% 2008
2023
Q2 		$87.4K Buy
+400
New +$89.2K ﹤0.01% 1712
2023
Q1 		– Sell
-600
Closed -$125K – 1661
2022
Q4 		$125K Sell
600
-4,200
-88% -$923K ﹤0.01% 1369
2022
Q3 		$1.05M Buy
4,800
+600
+14% +$137K 0.01% 988
2022
Q2 		$880K Sell
4,200
-4,700
-53% -$1M ﹤0.01% 1070
2022
Q1 		$2.16M Sell
8,900
-2,600
-23% -$629K 0.01% 1019
2021
Q4 		$3M Sell
11,500
-1,800
-14% -$467K 0.01% 982
2021
Q3 		$3.5M Buy
13,300
+12,100
+1,008% +$3.31M 0.01% 978
2021
Q2 		$296K Sell
1,200
-700
-37% -$147K ﹤0.01% 1457
2021
Q1 		$369K Sell
1,900
-2,700
-59% -$541K ﹤0.01% 1336
2020
Q4 		$978K Buy
4,600
+1,800
+64% +$359K ﹤0.01% 1090
2020
Q3 		$480K Sell
2,800
-1,900
-40% -$351K ﹤0.01% 1177
2020
Q2 		$902K Buy
+4,700
New +$769K 0.01% 949
2020
Q1 		– Sell
-2,400
Closed -$372K – 1359
2019
Q4 		$372K Sell
2,400
-3,600
-60% -$519K ﹤0.01% 1192
2019
Q3 		$811K Buy
6,000
+2,900
+94% +$380K 0.01% 989
2019
Q2 		$378K Buy
3,100
+400
+15% +$44.3K ﹤0.01% 1159
2019
Q1 		$281K Buy
2,700
+1,300
+93% +$134K ﹤0.01% 1086
2018
Q4 		$159K Buy
+1,400
New +$150K ﹤0.01% 1062

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capstone Investment Advisors's RMD Position: Q1 2026 in Review

Capstone Investment Advisors reduced its ResMed (RMD) stake by 5.9% in Q1 2026, selling an estimated $40.4K and leaving 2,563 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.

Capstone Investment Advisors first reported a position in RMD in Q4 2015 and has held it in 20 quarters since. The position peaked at $2.33M in Q3 2016. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Capstone Investment Advisors held 2,563 shares of ResMed worth $575K as of Q1 2026.
  • Capstone Investment Advisors sold 162 ResMed shares in Q1 2026, an estimated $40.4K.
  • ResMed made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1080 holding.
  • Capstone Investment Advisors first reported a position in ResMed in Q4 2015 and has held it in 20 quarters since.
  • Capstone Investment Advisors's ResMed position peaked at $2.33M in Q3 2016.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.